Loading company
Loading
Latest annual · FY2025
Millions- Free cash flow
- (2)
Latest quarter · Q2 FY2026
Millions- Operating income
- (1)
- Net income
- (1)
Kraig Biocraft Laboratories, Inc. (KBLB) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Cash from operating activities | -$1.8 million | -$1.8 million | 10-K 2026-03-30 · proof | |
| Free cash flow | -$1.8 million | -$1.8 million | 10-K 2026-03-30 · proof | |
| Total assets | $2.6 million | $1.5 million | +70.4% | 10-K 2026-03-30 · proof |
| Total liabilities | $10.6 million | $9.7 million | +9.4% | 10-K 2026-03-30 · proof |
| Cash and cash equivalents | $1.8 million | $673,264 | +165.9% | 10-K 2026-03-30 · proof |
- What was Kraig Biocraft Laboratories, Inc. (KBLB)'s cash from operating activities in fiscal 2025?
- Kraig Biocraft Laboratories, Inc. (KBLB) reported cash from operating activities of -$1.8 million for fiscal 2025 (the year ended Dec 31, 2025), against -$1.8 million the year before. Source: the 10-K filed with the SEC on Mar 30, 2026. SEC
- What was Kraig Biocraft Laboratories, Inc. (KBLB)'s free cash flow in fiscal 2025?
- Kraig Biocraft Laboratories, Inc. (KBLB) reported free cash flow of -$1.8 million for fiscal 2025 (the year ended Dec 31, 2025), against -$1.8 million the year before. Source: the 10-K filed with the SEC on Mar 30, 2026. SEC
- What are Kraig Biocraft Laboratories, Inc. (KBLB)'s total assets?
- As of Dec 31, 2025, Kraig Biocraft Laboratories, Inc. (KBLB) reported total assets of $2.6 million, against $1.5 million a year earlier (+70.4%). Source: the 10-K filed with the SEC on Mar 30, 2026. SEC
- What are Kraig Biocraft Laboratories, Inc. (KBLB)'s total liabilities?
- As of Dec 31, 2025, Kraig Biocraft Laboratories, Inc. (KBLB) reported total liabilities of $10.6 million, against $9.7 million a year earlier (+9.4%). Source: the 10-K filed with the SEC on Mar 30, 2026. SEC
- What are Kraig Biocraft Laboratories, Inc. (KBLB)'s cash and cash equivalents?
- As of Dec 31, 2025, Kraig Biocraft Laboratories, Inc. (KBLB) reported cash and cash equivalents of $1.8 million, against $673,264 a year earlier (+165.9%). Source: the 10-K filed with the SEC on Mar 30, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:KBLB&period_type=annual&limit=5"Information only, not investment advice.